BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3278186)

  • 21. Can mumps vaccine induce remission in recurrent respiratory papilloma?
    Pashley NR
    Arch Otolaryngol Head Neck Surg; 2002 Jul; 128(7):783-6. PubMed ID: 12117334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrent respiratory papillomatosis.
    Tasca RA; Clarke RW
    Arch Dis Child; 2006 Aug; 91(8):689-91. PubMed ID: 16861486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Molecular-biological aspects of juvenile respiratory papillomatosis and its combined treatment].
    Geraĭn V; Chireshkin DG
    Vestn Otorinolaringol; 1996; (4):3-8. PubMed ID: 8966875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of human papilloma virus types on course of juvenile respiratory papillomatosis and effectiveness of interferon therapy in children].
    Nurmukhametov RKh; Onufrieva EK; Soldatskiĭ IuL; Brodskiĭ MIu
    Vestn Otorinolaringol; 2000; (2):37-40. PubMed ID: 10771610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural cytotoxicity and interferon production in patients with recurrent respiratory papillomatosis.
    Naiman HB; Doyle AT; Ruben RJ; Kadish AS
    Ann Otol Rhinol Laryngol; 1984; 93(5 Pt 1):483-7. PubMed ID: 6437314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Assessment of the formation of antibodies to interferon in patients with juvenile respiratory papillomatosis on interferon therapy].
    Kol'tsov VD; Chireshkin DG; Onufrieva EK; Nurmukhametov RKh; Malinovskaia VV; Ershov FI
    Vestn Otorinolaringol; 1996; (4):25-7. PubMed ID: 8966873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Side effects and toxicity of interferon in the treatment of recurrent respiratory papillomatosis.
    Crockett DM; McCabe BF; Lusk RP; Mixon JH
    Ann Otol Rhinol Laryngol; 1987; 96(5):601-7. PubMed ID: 3674659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent respiratory papillomatosis.
    Long YT; Sani A
    Asian J Surg; 2003 Apr; 26(2):112-6. PubMed ID: 12732496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Juvenile laryngeal papillomatosis and epidermoid carcinoma.
    Chaput M; Ninane J; Gosseye S; Moulin D; Hamoir M; Claus D; Francis C; Richard F; Vermylen C; Cornu G
    J Pediatr; 1989 Feb; 114(2):269-72. PubMed ID: 2536808
    [No Abstract]   [Full Text] [Related]  

  • 30. Initial results from the national registry for juvenile-onset recurrent respiratory papillomatosis. RRP Task Force.
    Armstrong LR; Derkay CS; Reeves WC
    Arch Otolaryngol Head Neck Surg; 1999 Jul; 125(7):743-8. PubMed ID: 10406310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon therapy for laryngeal papillomatosis in adults.
    Bomholt A
    Arch Otolaryngol; 1983 Aug; 109(8):550-2. PubMed ID: 6870649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cidofovir efficacy in recurrent respiratory papillomatosis: a randomized, double-blind, placebo-controlled study.
    McMurray JS; Connor N; Ford CN
    Ann Otol Rhinol Laryngol; 2008 Jul; 117(7):477-83. PubMed ID: 18700421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Interferon in the treatment of recurrent laryngeal papillomas].
    Lenarcić-Cepelja I; Krajina Z
    Laryngol Rhinol Otol (Stuttg); 1984 Aug; 63(8):401-2. PubMed ID: 6482620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. American Society of Pediatric Otolaryngology members' experience with recurrent respiratory papillomatosis and the use of adjuvant therapy.
    Schraff S; Derkay CS; Burke B; Lawson L
    Arch Otolaryngol Head Neck Surg; 2004 Sep; 130(9):1039-42. PubMed ID: 15381589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of remission in juvenile-onset recurrent respiratory papillomatosis.
    Ruparelia S; Unger ER; Nisenbaum R; Derkay CS; Reeves WC
    Arch Otolaryngol Head Neck Surg; 2003 Dec; 129(12):1275-8. PubMed ID: 14676151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Combined treatment in recurrent laryngeal papillomatosis with CO2 laser microlaryngoscopic resection and interferon alpha 2b].
    Montero Mora P; Hernández Colín DD; Enríquez Palomec O; Mejía Ortega J
    Rev Alerg Mex; 1996; 43(5):133-6. PubMed ID: 9005006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis.
    Kashima HK; Shah F; Lyles A; Glackin R; Muhammad N; Turner L; Van Zandt S; Whitt S; Shah K
    Laryngoscope; 1992 Jan; 102(1):9-13. PubMed ID: 1309932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Quantitative evaluation of the focus range of juvenile onset recurrent respiratory papillomatosis].
    Lei W; Su Z; Wen W; Chai L; Jiang A; Luo G; Li J
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Nov; 20(21):970-2. PubMed ID: 17219992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The schedule of intralesional papillomatosis treatment with cidofovir].
    Szyfter W; Wierzbicka M; Jackowska J; Bartochowska A; Banaszewski J
    Otolaryngol Pol; 2010; 64(2):98-102. PubMed ID: 20568538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isotretinoin therapy for recurrent respiratory papillomatosis.
    Eicher SA; Taylor-Cooley LD; Donovan DT
    Arch Otolaryngol Head Neck Surg; 1994 Apr; 120(4):405-9. PubMed ID: 8166969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.